Effect of Hepatosteatosis on the Virological Response in Entecavir and Tenofovir Therapies

KORKMAZ P., Demirturk N., Batirel A., Tulek N., Ozguler M., Harman R., ...More

KLIMIK JOURNAL, vol.32, no.3, pp.265-274, 2019 (Journal Indexed in ESCI) identifier identifier

  • Publication Type: Article / Article
  • Volume: 32 Issue: 3
  • Publication Date: 2019
  • Doi Number: 10.5152/kd.2019.73
  • Title of Journal : KLIMIK JOURNAL
  • Page Numbers: pp.265-274


Objective: Both chronic hepatitis B (CHB) and hepatosteatosis may lead to necroinflammation in liver. Therefore, the presence of hepatosteatosis might negatively affect the efficacy of antiviral therapy. We aimed to determine the effect of hepatosteatosis on virological response in patients with CHB receiving entecavir (ETV) and tenofovir (TDF) treatment.